Haploidentical stem cell transplantation with posttransplant cyclophosphamide in children with Wiskott–Aldrich syndrome: a case report

Haploidentical stem cell transplantation with posttransplant cyclophosphamide in children with Wiskott–Aldrich syndrome: a case report

Wiskott–Aldrich syndrome (WAS) is a condition characterized by a low platelet count, eczema, and a weakened immune system. Hematopoietic stem cell transplantation (HSCT) is the only curative treatment option. Haploidentical HSCT with posttransplant cyclophosphamide (PTCy) is an emerging approach for...

Full description

Saved in:

Bibliographic Details
Main Authors:	Le Nguyen Ngoc Quynh, Binh Nguyen Thanh, Lien Luong Thi, Thuy Nguyen Thi Dieu, Duong Dang Anh, Pamela P. Lee, Tung Cao Viet, Dien Tran Minh
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-02-01
Series:	Frontiers in Immunology
Subjects:	Wiskott–Aldrich syndrome thrombocytopenia inborn error immunity hematopoietic stem cell transplantation posttransplant cyclophosphamide
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1495666/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

New insights into Wiskott-Aldrich syndrome: ten novel WAS mutations and their clinical impact in a Brazilian cohort
by: Lucas W. Santos, et al.
Published: (2025-07-01)

A case of Wiskott — Aldrich syndrome in an infant
by: E. V. Churyukina, et al.
Published: (2023-10-01)

CASE REPORT: FAMILIAL WISKOTT-ALDRICH SYNDROME
by: Belykh Natalia Anatolievna, et al.
Published: (2024-12-01)

X-linked Thrombocytopenia with Normal Wiskott-Aldrich Syndrome Protein Expression in Lymphocytes and a Novel Wiskott-Aldrich Syndrome Protein Gene Variant: A Case Report and Brief Review of the Literature
by: Serena Hamanaka, MD, et al.
Published: (2024-12-01)

The Misleading Normal in an Unusual Case of Wiskott–Aldrich Syndrome: A Case Report with Review of Literature
by: Vanya Rai, et al.

When Immunodeficiency Meets Neurosurgery: Brain Abscess in a Wiskott-Aldrich Syndrome Patient
by: Jayasooriya HK, et al.
Published: (2025-01-01)

Long-term outcome in Wiskott-Aldrich syndrome and X-linked thrombocytopenia patients: an observational -prospective multi-center study of the Italian Primary Immune Deficiency Network (IPINET)Research in context
by: Annarosa Soresina, et al.
Published: (2025-06-01)

Characterization of a WAS splice-site variant in a patient with Wiskott-Aldrich syndrome
by: Elisabetta Toriello, et al.
Published: (2025-01-01)

Multifocal Leukoencephalopathy
by: J Gordon Millichap
Published: (1994-05-01)

Current status of conditioning regimens in haploidentical hematopoietic cell transplantation
by: Junichi Sugita, et al.
Published: (2024-12-01)

Impact of inhibitory KIR ligand mismatch and other variables on outcomes following myeloablative posttransplant cyclophosphamide-based T-cell-replete haploidentical bone marrow transplantation
by: Sarah Kayser, et al.
Published: (2024-12-01)

Immune Reconstitution after Haploidentical Hematopoietic Stem Cell Transplantation with Different Non‐T‐Cell Depletion Protocols
by: Xiao‐Di Ma, et al.
Published: (2025-06-01)

Advancing Newborn Screening in Washington State: A Novel Multiplexed LC-MS/MS Proteomic Assay for Wilson Disease and Inborn Errors of Immunity
by: Claire Klippel, et al.
Published: (2025-01-01)

Rare Case of Congenital Thrombotic Thrombocytopenic Purpura Presenting as Posttransplant Thrombotic Microangiopathy
by: Akila Viswanathan, et al.
Published: (2024-12-01)

The prognostic value of posttransplant chimerism
by: A. A. Sipol, et al.
Published: (2022-11-01)

Post-transplant cyclophosphamide or cell selection in haploidentical allogeneic hematopoietic cell transplantation?
by: Razan Mohty, et al.
Published: (2024-12-01)

Haploidentical Stem Cell Transplantation With Dual Source of Cells and Post‐Transplant Cyclophosphamide
by: Ana Marcela Rojas Fonseca‐Hial, et al.
Published: (2025-02-01)

Changing trends in the management of posttransplant ureteric stricture
by: Sunirmal Choudhury, et al.
Published: (2024-01-01)

Pharmacokinetics of post-transplant cyclophosphamide and its associations with clinical outcomes in pediatric haploidentical hematopoietic stem cell transplantation
by: Kyung Taek Hong, et al.
Published: (2025-03-01)

IMMUNITY TO INFECTIONS AFTER HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION
by: Franco Aversa, et al.
Published: (2016-10-01)

Metagenomic analysis of DNA viruses from posttransplant lymphoproliferative disorders
by: Vikas R. Dharnidharka, et al.
Published: (2019-03-01)

Daratumumab for refractory posttransplant autoimmune hemolytic anemia: An option beyond the obvious
by: Sreedhar Jayakrishnan Cherulil, et al.
Published: (2025-01-01)

More about post-transplant cyclophosphamide in haploidentical grafts: full or reduced doses?
by: Moisés Manuel Gallardo-Pérez, et al.
Published: (2024-12-01)

Outcomes of haploidentical vs mismatched unrelated donor HCT with posttransplant cyclophosphamide prophylaxis
by: Yosra M. Aljawai, et al.
Published: (2025-08-01)

Síndrome de Wiskott Aldrich. Presentación de un caso
by: Maria del Carmen Garcia, et al.
Published: (2014-09-01)

Atypical presentation of Wiskott–Aldrich syndrome with autoimmune arthritis and macrothrombocytopenia
by: Sunil Vishan Kapur, et al.
Published: (2021-01-01)

Guillain-Barré syndrome in an immunocompromised patient with Wiskott-Aldrich syndrome
by: Akgün Olmez, et al.
Published: (2008-08-01)

Myeloablative Conditioning with PBSC Grafts for T Cell-Replete Haploidentical Donor Transplantation Using Posttransplant Cyclophosphamide
by: Scott R. Solomon, et al.
Published: (2016-01-01)

Protective effects and metabolomics analysis of dihydromyricetin on cyclophosphamide-induced hepatotoxicity in mice
by: Fei Teng, et al.
Published: (2025-12-01)

Cyclophosphamide: An Overview
by: Aditya Kumar Bubna
Published: (2025-01-01)

A case of Wiskott-Aldrich syndrome with de novo mutation at exon 4
by: Figen Doğu, et al.
Published: (2006-01-01)

Impact of post-transplant cyclophosphamide with bendamustine on immune reconstitution in young patients undergoing T-cell replete haploidentical bone marrow transplantation: results from a phase Ia/Ib clinical trial
by: Forrest L. Baker, et al.
Published: (2025-04-01)

Correction: Impact of post-transplant cyclophosphamide with bendamustine on immune reconstitution in young patients undergoing T-cell replete haploidentical bone marrow transplantation: results from a phase Ia/Ib clinical trial
by: Forrest L. Baker, et al.
Published: (2025-06-01)

Genetic Polymorphisms Associated with Cyclophosphamide Outcome and Risk of Toxicity in Patients with Lupus Nephritis
by: Yen Yen Ari Indrawijaya, et al.
Published: (2023-11-01)

Rapidly progressive pleuro-parenchymal fibroelastosis secondary to cyclophosphamide chemotherapy
by: Maheema Bhaskar, et al.
Published: (2020-01-01)

Steroid-Resistant Nephrotic Syndrome due to NPHS2 Variants Is Not Associated With Posttransplant Recurrence
by: Jessica Kachmar, et al.
Published: (2024-04-01)

Experimental Study on Cytoflavin Pharmacological Correction of Cyclophosphamide-Induced Toxic Affections of the Liver and Kidneys
by: V. A. Kashuro, et al.
Published: (2020-05-01)

Clinical and molecular findings in actin-related inborn errors of immunity: the middle East and North Africa registry
by: Zahra Chavoshzadeh, et al.
Published: (2025-08-01)

Wiskott-Aldrich Syndrome Presenting with JMML-Like Blood Picture and Normal Sized Platelets
by: Rajesh B. Patil, et al.
Published: (2016-01-01)

Development of central nervous system autoimmunity is impaired in the absence of Wiskott-Aldrich syndrome protein.
by: Marita Bosticardo, et al.
Published: (2014-01-01)